methotrexate has been researched along with Facial Hemiatrophy in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Bassi, A; Belloni Fortina, A; Bonamonte, D; Brazzelli, V; Cambiaghi, S; DI Lernia, V; Diociaiuti, A; El Hachem, M; Neri, I; Patrizi, A; Pepe, P; Schena, D; Virdi, A | 1 |
| Chhabra, A; Lam, JM; Rhemus, W | 1 |
| Anderson, LE; Knight, AM; Kreiger, PA; Licht, DJ; Treat, JR | 1 |
| Gan, JJL; Iqbal, T; Koleva, E; Kuah, CY | 1 |
| Benamara-Levy, M; Bodemer, C; Dionne, MC; Le Sache de Peufheiloux, L; Leducq, S; Maruani, A; Samimi, M | 1 |
| Al Enezi, S; Al Khalaf, MK; Al Mutairi, MA; Zakkiriah, M | 1 |
| Adapinar, B; Korkmaz, C; Uysal, S | 1 |
| Tollefson, MM; Witman, PM | 1 |
| Ball, WS; deGrauw, T; Goldberg-Stern, H; Passo, M | 1 |
3 review(s) available for methotrexate and Facial Hemiatrophy
| Article | Year |
|---|---|
Remission of seizures with immunosuppressive therapy in Parry-Romberg syndrome and en coup de sabre linear scleroderma: Case report and brief review of the literature.
Topics: Brain; Child; Facial Hemiatrophy; Female; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Methotrexate; Remission Induction; Scleroderma, Localized; Seizures; Skin | 2018 |
Treatments and outcomes in juvenile linear scleroderma: a narrative systematic review.
Topics: Facial Hemiatrophy; Humans; Immunosuppressive Agents; Methotrexate; Scleroderma, Localized; Steroids; Treatment Outcome; Ultraviolet Therapy | 2018 |
Beneficial effect of immunosuppressive drugs on Parry-Romberg syndrome: a case report and review of the literature.
Topics: Adult; Alopecia; Facial Hemiatrophy; Humans; Immunosuppressive Agents; Male; Methotrexate | 2005 |
6 other study(ies) available for methotrexate and Facial Hemiatrophy
| Article | Year |
|---|---|
A retrospective study on clinical subtypes and management of morphea in 10 Italian Dermatological Units.
Topics: Child; Child, Preschool; Facial Hemiatrophy; Humans; Italy; Methotrexate; Retrospective Studies; Scleroderma, Localized | 2021 |
Tongue Involvement in Parry-Romberg Syndrome.
Topics: Adolescent; Atrophy; Child, Preschool; Disease Progression; Facial Hemiatrophy; Female; Glucocorticoids; Humans; Methotrexate; Prednisone; Tongue | 2017 |
Parry-Romberg syndrome in a patient with scleroderma.
Topics: Dermatologic Agents; Facial Hemiatrophy; Female; Humans; Methotrexate; Middle Aged; Scleroderma, Localized | 2018 |
Parry-Romberg syndrome in Kuwait. Neurological manifestations in 2 children.
Topics: Adolescent; Anticonvulsants; Atrophy; Cerebrum; Child; Electroencephalography; Epilepsies, Partial; Facial Hemiatrophy; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Ischemic Attack, Transient; Kuwait; Magnetic Resonance Imaging; Male; Methotrexate; Prednisolone | 2019 |
En coup de sabre morphea and Parry-Romberg syndrome: a retrospective review of 54 patients.
Topics: Adolescent; Adult; Aged; Child; Dermatologic Agents; Disease Progression; Facial Hemiatrophy; Female; Humans; Male; Methotrexate; Middle Aged; Retrospective Studies; Scleroderma, Localized; Seizures | 2007 |
Parry-Romberg syndrome: follow-up imaging during suppressive therapy.
Topics: Brain; Child; Facial Hemiatrophy; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Methotrexate; Prednisone | 1997 |